S/N |
Indicator Code |
Indicator Name |
Indicator Type |
Indicator Answer |
Extended Name |
Denominator |
Frequency |
1 |
POI1 |
Average turn-around time for TB GeneXpert test (Hrs) |
Project Outcome Indicator |
Number |
|
Yes |
Quarterly |
2 |
POI2 |
What is the SLIPTA star rating of the laboratory from the last assessment? |
Project Outcome Indicator |
Boolean |
|
Yes |
Annually |
3 |
POI3 |
Number of beneficiaries (out of which x % female). |
Project Outcome Indicator |
Number and Percentage |
|
Yes |
Quarterly |
4 |
POI4 |
People receiving TB drug susceptibility tests among DOTS treated TB cases not responding to treatment (number, percent). |
Project Outcome Indicator |
Number and Percentage |
|
Yes |
Annually |
5 |
POI5 |
Proportion of reported communicable disease outbreaks having laboratory confirmation of etiological agent (percent). |
Project Outcome Indicator |
Number |
|
Yes |
Annually |
6 |
POI6 |
Proportion of outbreaks in cross border areas that joint investigations were done (both in country joint investigations and inter-country joint investigations) |
Project Outcome Indicator |
Number |
|
Yes |
Annually |
7 |
IOI1 |
Satellite laboratories compliant with WHO SOPs (cumulative number, percent). |
Intermediate Outcome Indicator |
Boolean |
|
Yes |
Annually |
8 |
IOI2 |
Number of days the national reference laboratory reporting stock-out of tracer reagent for TB liquid culture in past quarter (days). |
Intermediate Outcome Indicator |
Number |
|
Yes |
Quarterly |
9 |
IOI3 |
Satellite laboratories reporting stock-outs of tracer reagent for stools culture (percent) |
Intermediate Outcome Indicator |
Boolean |
|
Yes |
Quarterly |
10 |
IOI4 |
Number of Health facilities |
Intermediate Outcome Indicator |
Number |
Equipped |
Yes |
Annually |
11 |
IOI4 |
Number of Health facilities |
Intermediate Outcome Indicator |
Number |
Renovated |
Yes |
Annually |
12 |
IOI4 |
Number of Health facilities |
Intermediate Outcome Indicator |
Number |
Constructed |
Yes |
Annually |
13 |
IOI5 |
Share of national and satellite laboratories that comply with Biomedical Waste Management requirements (cumulative number, percent) |
Intermediate Outcome Indicator |
Boolean |
|
Yes |
Annually |
14 |
IOI6 |
Quarterly publication of a regional surveillance bulletin by East Africa integrated disease surveillance network with country-specific data (yes/no). |
Intermediate Outcome Indicator |
Boolean |
|
Yes |
Quarterly |
15 |
IOI7 |
Health personnel receiving training (number) |
Intermediate Outcome Indicator |
Number |
|
Yes |
Annually |
16 |
IOI8 |
Proportion of laboratory staff trained and found to be proficient (Competent) in performing assignments |
Intermediate Outcome Indicator |
Number |
|
Yes |
Annually |
17 |
IOI9 |
Operational Research studies |
Intermediate Outcome Indicator |
Number |
Developed and approved by a recognized IRB. |
Yes |
Annually |
18 |
IOI9 |
Operational Research studies |
Intermediate Outcome Indicator |
Number |
Completed with results disseminated. |
Yes |
Annually |
19 |
IOI9 |
Operational Research studies |
Intermediate Outcome Indicator |
Number |
Offshoot proposals developed for short term operational studies. |
Yes |
Annually |
20 |
IOI10 |
Number of GeneXpert tests performed |
Intermediate Outcome Indicator |
Number |
|
Yes |
Quarterly |
21 |
IOI11 |
Number of laboratory tests performed |
Intermediate Outcome Indicator |
Number |
|
Yes |
Quarterly |
22 |
IOI12 |
Laboratory Clients Satisfaction Rate |
Intermediate Outcome Indicator |
Number |
|
Yes |
Annually |